These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23908471)

  • 1. Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease.
    Veerapathran A; Pidala J; Beato F; Betts B; Kim J; Turner JG; Hellerstein MK; Yu XZ; Janssen W; Anasetti C
    Blood; 2013 Sep; 122(13):2251-61. PubMed ID: 23908471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II.
    van Balen P; van Bergen CAM; van Luxemburg-Heijs SAP; de Klerk W; van Egmond EHM; Veld SAJ; Halkes CJM; Zwaginga JJ; Griffioen M; Jedema I; Falkenburg JHF
    Front Immunol; 2018; 9():3016. PubMed ID: 30619360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 clone.
    Eljaafari A; Yuruker O; Ferrand C; Farre A; Addey C; Tartelin ML; Thomas X; Tiberghien P; Simpson E; Rigal D; Scott D
    J Immunol; 2013 Jan; 190(1):184-94. PubMed ID: 23225889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly.
    Veerapathran A; Pidala J; Beato F; Yu XZ; Anasetti C
    Blood; 2011 Nov; 118(20):5671-80. PubMed ID: 21948174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models.
    Duramad O; Laysang A; Li J; Ishii Y; Namikawa R
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1154-68. PubMed ID: 21145405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.
    Leclerc M; Naserian S; Pilon C; Thiolat A; Martin GH; Pouchy C; Dominique C; Belkacemi Y; Charlotte F; Maury S; Salomon BL; Cohen JL
    Blood; 2016 Sep; 128(12):1651-9. PubMed ID: 27506541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT.
    Olsen KS; Jadi O; Dexheimer S; Bortone DS; Vensko SP; Bennett S; Tang H; Diiorio M; Saran T; Dingfelder D; Zhu Q; Wang Y; Haiman CA; Pooler L; Sheng X; Webb A; Pasquini MC; McCarthy PL; Spellman SR; Weimer E; Hahn T; Sucheston-Campbell L; Armistead PM; Vincent BG
    Blood Adv; 2023 May; 7(9):1635-1649. PubMed ID: 36477467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
    Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg JH; Vossen J; Gratwohl A; Vogelsang GB; van Houwelingen HC; van Rood JJ
    N Engl J Med; 1996 Feb; 334(5):281-5. PubMed ID: 8532022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.
    Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX
    Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease.
    Kim BS; Nishikii H; Baker J; Pierini A; Schneidawind D; Pan Y; Beilhack A; Park CG; Negrin RS
    Blood; 2015 Jul; 126(4):546-57. PubMed ID: 26063163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minor histocompatibility antigen-specific cytotoxic T lymphocytes generated with dendritic cells from DLA-identical littermates.
    Georges GE; Lesnikova M; Storb R; Yunusov M; Little MT; Nash RA
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):234-42. PubMed ID: 12720216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human LAP
    Wang H; Song H; Pham AV; Cooper LJ; Schulze JJ; Olek S; Tran DQ
    Theranostics; 2019; 9(8):2315-2324. PubMed ID: 31149046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple in vitro generation of human leukocyte antigen-G-expressing T-regulatory cells through pharmacological hypomethylation for adoptive cellular immunotherapy against graft-versus-host disease.
    Stamou P; Marioli D; Patmanidi AL; Sgourou A; Vittoraki A; Theofani E; Pierides C; Taraviras S; Costeas PA; Spyridonidis A
    Cytotherapy; 2017 Apr; 19(4):521-530. PubMed ID: 28162915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct expansion of human allospecific FoxP3+CD4+ regulatory T cells with allogeneic B cells for therapeutic application.
    Chen LC; Delgado JC; Jensen PE; Chen X
    J Immunol; 2009 Sep; 183(6):4094-102. PubMed ID: 19684083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-Scale Generation of Human Allospecific Induced Tregs With Functional Stability for Use in Immunotherapy in Transplantation.
    Alvarez-Salazar EK; Cortés-Hernández A; Arteaga-Cruz S; Alberú-Gómez J; Soldevila G
    Front Immunol; 2020; 11():375. PubMed ID: 32300340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
    Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
    Front Immunol; 2018; 9():3104. PubMed ID: 30733722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HY-Specific Induced Regulatory T Cells Display High Specificity and Efficacy in the Prevention of Acute Graft-versus-Host Disease.
    Li J; Heinrichs J; Haarberg K; Semple K; Veerapathran A; Liu C; Anasetti C; Yu XZ
    J Immunol; 2015 Jul; 195(2):717-25. PubMed ID: 26048147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.
    Ofran Y; Kim HT; Brusic V; Blake L; Mandrell M; Wu CJ; Sarantopoulos S; Bellucci R; Keskin DB; Soiffer RJ; Antin JH; Ritz J
    Clin Cancer Res; 2010 Mar; 16(5):1642-51. PubMed ID: 20160060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.